Literature DB >> 25225773

Current recommendations and emerging options for the treatment of allergic rhinitis.

Amelia Licari1, Giorgio Ciprandi, Alessia Marseglia, Riccardo Castagnoli, Salvatore Barberi, Silvia Caimmi, Gian Luigi Marseglia.   

Abstract

Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.

Entities:  

Keywords:  allergic rhinitis; drugs; efficacy; immunology; inflammation; safety; therapy

Mesh：

Substances：

Year:  2014        PMID： 25225773     DOI： 10.1586/1744666X.2014.955476

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


  14 in total

Review 1.  An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases.

Authors:  Amelia Licari; Riccardo Castagnoli; Elisa Panfili; Alessia Marseglia; Ilaria Brambilla; Gian Luigi Marseglia
Journal:  Curr Respir Med Rev       Date:  2017-03

2.  Broad Th2 neutralization and anti-inflammatory action of pentosan polysulfate sodium in experimental allergic rhinitis.

Authors:  Caroline Sanden; Michiko Mori; Prajakta Jogdand; Jimmie Jönsson; Ravi Krishnan; Xiangdong Wang; Jonas S Erjefält
Journal:  Immun Inflamm Dis       Date:  2017-05-12

3.  Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies.

Authors:  Paul Ratner; Charles P Andrews; Frank C Hampel; Bruce Martin; Dale E Mohar; Denis Bourrelly; Parisa Danaietash; Sara Mangialaio; Jasper Dingemanse; Abdel Hmissi; Jay van Bavel
Journal:  Allergy Asthma Clin Immunol       Date:  2017-04-04       Impact factor: 3.406

Review 4.  The Nose and the Lung: United Airway Disease?

Authors:  Amelia Licari; Riccardo Castagnoli; Chiara Francesca Denicolò; Linda Rossini; Alessia Marseglia; Gian Luigi Marseglia
Journal:  Front Pediatr       Date:  2017-03-03       Impact factor: 3.418

5.  Mesenchymal stromal cells ameliorate acute allergic rhinitis in rats.

Authors:  Chunlei Li; Yanxia Fu; Yinyin Wang; Yanhua Kong; Mengdi Li; Danhui Ma; Wanli Zhai; Hao Wang; Yuting Lin; Sihan Liu; Fangli Ren; Jun Li; Yi Wang
Journal:  Cell Biochem Funct       Date:  2017-09-20       Impact factor: 3.685

6.  Inhibitory Effects of AF-343, a Mixture of Cassia tora L., Ulmus pumila L., and Taraxacum officinale, on Compound 48/80-Mediated Allergic Responses in RBL-2H3 Cells.

Authors:  Eun Kyeong Lee; Jeongah Song; Youjin Seo; Eun Mi Koh; Seon-Hee Kim; Kyung Jin Jung
Journal:  Molecules       Date:  2020-05-22       Impact factor: 4.411

7.  The Anti-Allergic Rhinitis Effect of Traditional Chinese Medicine of Shenqi by Regulating Mast Cell Degranulation and Th1/Th2 Cytokine Balance.

Authors:  Yang-Yang Shao; Yi-Ming Zhou; Min Hu; Jin-Ze Li; Cheng-Juan Chen; Yong-Jiang Wang; Xiao-Yun Shi; Wen-Jie Wang; Tian-Tai Zhang
Journal:  Molecules       Date:  2017-03-22       Impact factor: 4.411

8.  Ethnobotanical study of curative plants used by traditional healers to treat rhinitis in the Limpopo Province, South Africa.

Authors:  Sebua Silas Semenya; Alfred Maroyi
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

9.  Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-β, IFN-γ, IL 22, and IL-35.

Authors:  P Bayrak Degirmenci; S Aksun; Z Altin; F Bilgir; I B Arslan; H Colak; B Ural; D Solakoglu Kahraman; G Diniz; B Ozdemir; C Kırmaz
Journal:  Dis Markers       Date:  2018-03-06       Impact factor: 3.434

10.  Geraniol suppresses proinflammatory mediators in phorbol 12-myristate 13-acetate with A23187-induced HMC-1 cells.

Authors:  Yue Huang; Xiao-Lin Yang; Yi-Hua Ni; Zheng-Min Xu
Journal:  Drug Des Devel Ther       Date:  2018-09-11       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.